Benjamin Richard J (CIK 1296322) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-16). Recent activity: Sell CERS (101,740 shares), Buy CERS (55,220 shares), Sell CERS (61,233 shares), Sell CERS (24,235 shares), Sell CERS (40,426 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-16 | CERUS CORP (CERS) | Chief Medical Officer | Sell | 101,740 | $168,888 |
| 2026-03-10 | CERUS CORP (CERS) | Chief Medical Officer | Buy | 55,220 | $0 |
| 2026-03-10 | CERUS CORP (CERS) | Chief Medical Officer | Sell | 61,233 | $126,140 |
| 2026-03-10 | CERUS CORP (CERS) | Chief Medical Officer | Sell | 24,235 | $48,712 |
| 2026-03-10 | CERUS CORP (CERS) | Chief Medical Officer | Sell | 40,426 | $76,001 |
| 2026-03-09 | CERUS CORP (CERS) | Chief Medical Officer | Buy | 55,220 | $0 |
| 2026-03-09 | CERUS CORP (CERS) | Chief Medical Officer | Sell | 61,233 | $126,140 |
| 2026-03-09 | CERUS CORP (CERS) | Chief Medical Officer | Sell | 24,235 | $48,712 |
| 2026-03-09 | CERUS CORP (CERS) | Chief Medical Officer | Sell | 40,426 | $76,001 |
| 2026-03-04 | CERUS CORP (CERS) | Chief Medical Officer | Buy | 264,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-03-16